EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting Supramolecular Active Complexes of Na v 1.7/Na v 1.8 to Relieve Chronic Neuropathic Pain

Liting Sun, Hang Xian, Yunxin Shi, Taotan Yang, Hongyan Shuai, Wenchao Hu, Siying Fei, Miao Xu, Taoyuan Yang, Ruilong Xia, Ting Wen, Fengting Zhu und 16 weitere

Advanced Science · 2026-07 · 13 (41)

DOI: 10.1002/advs.202522185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 20.05.2026. Verfasst von Liting Sun und 27 weiteren Autor:innen. Beteiligte Einrichtung: The First Rehabilitation Hospital of Shanghai, Brain and Spinal Cord Innovation Research Center, Translational Research Institute of Brain and Brain-…. Hauptthemen laut MEDLINE: Ganglia, Spinal, Neuralgia, NAV1.8 Voltage-Gated Sodium Channel, NAV1.7 Voltage-Gated Sodium Channel. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Major National Science and Technology Projects of China, Excellent Youth Science Foundation of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuropathic pain (NP) affects 7%–10% of population, with current treatments often proving inadequate. Here we show that Na v 1.7 and Na v 1.8 form supramolecular active complexes (SMACs) with polygonal lattice structure in dorsal root ganglion (DRG) neurons of mouse models and patients with severe chronic NP. TrkB signaling facilitates the formation of Na v 1.7/Na v 1.8 SMACs. Targeting these SMACs with combined Na v 1.7 and Na v 1.8 blockers inhibits action potentials of both human and mouse pathological DRG neurons and synergistically alleviates chronic NP in spared nerve injury (SNI) and diabetic mouse models. The SMAC formation is promoted by five cytoskeletal proteins (SPTAN1, DSP, AHNAK, MPZ and PRX). Functional study demonstrates that these SMACs create a Na + potential difference to amplify sodium currents, promoting DRG neuron hyperexcitability. Moreover, knockdown of these five cytoskeletal proteins prevents action potential generation in DRG neurons and eliminates NP in SNI mice. Our findings support that SMACs can be a potential pathological hallmark and novel promising therapeutic target for severe chronic NP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ganglia, SpinalNeuralgiaNAV1.8 Voltage-Gated Sodium ChannelNAV1.7 Voltage-Gated Sodium ChannelChronic PainAnimalsMiceHumansDisease Models, AnimalNeuronsMale

Stichwörter der Autor:innen

CrebDspSptan1TrkBchronic painpathological hallmarktargeted therapy

Substanzen

NAV1.8 Voltage-Gated Sodium ChannelNAV1.7 Voltage-Gated Sodium Channel

Autor:innen und Institutionen

  • The First Rehabilitation Hospital of Shanghai, Brain and Spinal Cord Innovation Research Center, Translational Research Institute of Brain and Brain-Like Intelligence,Shanghai Key Laboratory of Anesthesiology and Brain…
  • Department of Neurobiology, School of Basic Medicine, Fourth Military Medical University, Xi'an, China.
  • Department of Orthopedics, Xijing Hospital, Fourth Military Medical University, Xi'an, China.
  • Xiang-Xing College, Hunan University of Traditional Chinese Medicine, Changsha, China.
  • Pre-clinical College, Dali University, Dali, Yunnan, China.
  • Department of Anesthesiology and Perioperative medicine, Shanghai Fourth People's Hospital, Shanghai, China.

ORCID-Profile: Changgeng Peng

Förderung

  • National Natural Science Foundation of China
  • Major National Science and Technology Projects of China
  • Excellent Youth Science Foundation of Shaanxi Province
  • The second round of the three-year action plan for "strengthening and promoting Traditional Chinese Medicine" of Hongkou District
  • the Scientific and Technological Innovation 2030-major project of Brain Science and Brain-Like Intelligence Technology
  • Shanghai Fourth People's Hospital
  • Shanghai Municipal Commission for Science and Technology

Zitieren

APA

Sun, L., Xian, H., Shi, Y., Yang, T., Shuai, H., Hu, W., Fei, S., Xu, M., Yang, T., Xia, R., Wen, T., Zhu, F., Fu, Y., Li, Y., Xia, W., Qian, R., Liu, Y., Tian, Z., Li, L., …, & Peng, C. (2026). Targeting Supramolecular Active Complexes of Na v 1.7/Na v 1.8 to Relieve Chronic Neuropathic Pain. Advanced Science, 13(41). https://doi.org/10.1002/advs.202522185

Vancouver

Sun L, Xian H, Shi Y, Yang T, Shuai H, Hu W, et al. Targeting Supramolecular Active Complexes of Na v 1.7/Na v 1.8 to Relieve Chronic Neuropathic Pain. Advanced Science. 2026;13(41). doi:10.1002/advs.202522185

BibTeX
@article{Sun2026,
  author = {Sun, Liting and Xian, Hang and Shi, Yunxin and Yang, Taotan and Shuai, Hongyan and Hu, Wenchao and Fei, Siying and Xu, Miao and Yang, Taoyuan and Xia, Ruilong and Wen, Ting and Zhu, Fengting and Fu, Yan and Li, Yang and Xia, Wei and Qian, Ran and Liu, Yuanying and Tian, Zhicheng and Li, Lamei and Zhou, Qian and Xiong, Lize and Cong, Rui and Luo, Ceng and Wu, Shengxi and Shen, Xiafeng and Yu, Xin and Xie, Rou-Gang and Peng, Changgeng},
  title = {Targeting Supramolecular Active Complexes of Na v 1.7/Na v 1.8 to Relieve Chronic Neuropathic Pain},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {41},
  doi = {10.1002/advs.202522185}
}
Kostenlos starten →